Financial News

Amid criticism for its handling of another Alzheimer’s drug, FDA will decide this week whether to approve lecanemab

A damning new congressional report found the regulator didn’t follow the correct procedures when it approved Aduhelm in 2021
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback